ClinVar Miner

Submissions for variant NM_001127222.2(CACNA1A):c.5897G>A (p.Arg1966Gln)

gnomAD frequency: 0.00039  dbSNP: rs199886234
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000653359 SCV000521005 benign not provided 2019-06-03 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 23869231, 21703448, 28488083)
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000439336 SCV000538549 uncertain significance not specified 2016-10-31 criteria provided, single submitter clinical testing Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: This variant is present in ExAC with a MaxMAF of 0.06%. It is predicted to be pathogenic by predictive tools. It is not present in ClinVar. It has been seen in 1 patient with congenital hyperinsulinism and 1 with epilepsy.
Eurofins Ntd Llc (ga) RCV000439336 SCV000708577 benign not specified 2017-05-23 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001083556 SCV000775238 benign Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 2023-12-06 criteria provided, single submitter clinical testing
Ambry Genetics RCV002318412 SCV000850526 likely benign Inborn genetic diseases 2017-03-21 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Mendelics RCV000990165 SCV001141008 benign Episodic ataxia type 2 2023-08-22 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000653359 SCV001143338 benign not provided 2019-06-17 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.